Clinical Trials Sponsored by Cara Donohue

Total 5559 results

Cara Donohue

Withdrawn

Fatigue in Patients With Amyotrophic Lateral Sclerosis

Respiration Disorders | Amyotrophic Lateral Sclerosis | Dysphagia | Dyspnea

United States
Casa di Cura Dott. Pederzoli

Unknown

3D Laparoscopy Versus 2D Laparoscopy (Lap3D)

Colorectal Cancer | Inflammatory Bowel Disease

Italy
Michael Donahoe

Completed

Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations

IPF

United States
Casa di Cura Privata Villa Mafalda

Recruiting

Desogestrel Versus GnRH Antagonist in IVF/ICSI (DEGOS)

Infertility | IVF

Italy
Casa Di Cura Villa Serena SpA

Completed

Measurements of Diaphragmatic Mobility on COPD Patients

Pulmonary Disease, Chronic Obstructive

Italy
Casa di Cura Privata Villa Mafalda

Unknown

The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles (PPOS)

Infertility | IVF

Italy
UConn Health
Donaghue Medical Research Foundation

Completed

Prevention of Recurrent Aphthous Stomatitis Using Vitamins

Aphthous Stomatitis

United States
Yale University
Donaghue Medical Research Foundation

Completed

Nicotinic Receptor Augmentation of SSRI Antidepressants

Depressive Disorder

United States
UConn Health
Donaghue Medical Research Foundation

Completed

Contingency Management and Pharmacotherapy for Smoking Cessation (Donaghue)

Cigarette Smoking

United States
Casa di Cura Privata del Policlinico SpA

Recruiting

Transcranial Direct Current Stimulation and Dual Tasks (Tdcs&DT)

Parkinson Disease

Italy
Casa di Cura Privata del Policlinico SpA

Withdrawn

Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting (BELK@CCP) (BELK@CCP)

Stroke | Central Nervous System Diseases | Neuromuscular Diseases | Knee Instability
Casa di Cura Privata del Policlinico SpA

Completed

Mirror Therapy Efficacy in Upper Limb Rehabilitation Early After Stroke (MT)

Stroke, Acute
Johns Hopkins University
Donaghue Medical Research Foundation

Active, not recruiting

PICU Up!: A Pilot Stepped-wedge Trial of a Multicomponent Early Mobility Intervention for Critically Ill Children (PICU Up!)

Critical Illness

United States
Yale University
Donaghue Medical Research Foundation

Completed

Changing Lifestyles for Better Health

Type 2 Diabetes Mellitus

United States
Kaiser Permanente
Donaghue Medical Research Foundation

Completed

Evaluating the Impact of a Value-based Prescription Drug Formulary (VBF-e)

Value-Based Health Insurance

United States
Yale University
Donaghue Medical Research Foundation

Completed

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

Obesity | Binge Eating

United States
UConn Health
Donaghue Medical Research Foundation

Completed

Gambling and Brief Interventions

Gambling

United States
UConn Health
Donaghue Medical Research Foundation

Completed

Early Range of Motion Following Arthroscopic Rotator Cuff Repair

Rotator Cuff Disease

United States
Donaghue Medical Research Foundation
Yale University

Completed

Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)

Premenstrual Syndrome

United States
The Cleveland Clinic
Yale University; Donaghue Medical Research Foundation

Active, not recruiting

Patient Priority Care for Older Adults With Multiple Chronic Conditions (PPC-CCF)

Multiple Chronic Conditions

United States
Cara Medical Ltd

Recruiting

Cara CDRS (Conduction Disturbance Risk Score) 1.0 (CDRS)

Transcatheter Aortic Valve Replacement

Spain, Canada, Italy
Cara Medical Ltd

Recruiting

Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 (Cara CDRM)

Transcatheter Aortic Valve Replacement

United States
Cara Therapeutics, Inc.

Recruiting

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States, Korea, Republic of, Australia, Bulgaria, Germany, Hungary, Italy, Poland, Romania, Spain, Argentina, Brazil, Mexico
Cara Therapeutics, Inc.

Completed

CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients

Hemodialysis

United States
Cara Therapeutics, Inc.

Completed

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Uremic Pruritus

United States, Czechia, Hungary, Poland
Cara Therapeutics, Inc.

Completed

Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Uremic Pruritus

United States, Puerto Rico
Cara Therapeutics, Inc.

Completed

Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects

Healthy | Hemodialysis

United States
Cara Medical Ltd

Recruiting

Intra-procedural ECG Changes During TAVR

Transcatheter Aortic Valve Replacement | Conduction Disturbance

United States
Cara Therapeutics, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)

Pruritus | Notalgia Paresthetica

United States, Canada
Cara Therapeutics, Inc.

Approved for marketing

Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin

Uremic Pruritus
Cara Therapeutics, Inc.

Completed

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-2)

Uremic Pruritus

United States, Canada, Czechia, Australia, Germany, Hungary, Korea, Republic of, New Zealand, Poland, Taiwan, United Kingdom
Cara Therapeutics, Inc.

Completed

Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Uremic Pruritus

United States
Cara Therapeutics, Inc.

Completed

A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery

Post Abdominal Surgery Pain

United States
Cara Therapeutics, Inc.

Completed

Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery

Postoperative Pain

United States
Cara Therapeutics, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica

Pruritus | Notalgia Paresthetica

United States, Poland, Spain, Canada, Germany
Cara Therapeutics, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KIND-1)

Pruritus | Atopic Dermatitis

United States
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Cholestatic Pruritus

United States
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Uremic Pruritus

United States
Cara Therapeutics, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KARE)

Pruritus | Atopic Dermatitis

United States, Canada
Cara Therapeutics, Inc.

Completed

A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee

Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Cara Therapeutics, Inc.

Completed

Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects

Healthy

United States
Cara Therapeutics, Inc.

Completed

A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee

Osteoarthritis

United States
Cara Therapeutics, Inc.

Completed

Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus

Pruritus | Uremic Pruritus

United States
Cara Therapeutics, Inc.

Completed

Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

Acute Pain

United States
Cara Therapeutics, Inc.

Completed

A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery

Acute Pain

United States
VA Connecticut Healthcare System
Donaghue Medical Research Foundation

Completed

Cognitive Behavioral Therapy for Painful Diabetic Neuropathy

Diabetic Neuropathy
Kevin Donahue
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Gene Therapy for Post-Operative Atrial Fibrillation (AFGT01)

Atrial Fibrillation | Post-operative Atrial Fibrillation

United States
IRCCS San Raffaele
Casa di Cura del Policlinico di Milano

Recruiting

Neuroimaging Biomarkers Toward a Personalized Upper Limb Action Observation Treatment in Chronic Stroke Patients (BE-TOP)

Chronic Stroke

Italy

3

Subscribe